Ascentage Pharma Group Stock Market Value
| ASPHF Stock | USD 8.48 0.00 0.00% |
| Symbol | Ascentage |
Ascentage Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ascentage Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ascentage Pharma.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Ascentage Pharma on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Ascentage Pharma Group or generate 0.0% return on investment in Ascentage Pharma over 90 days. Ascentage Pharma is related to or competes with OUTLOOK THERAPEUTICS, NRX Pharmaceuticals, Spruce Biosciences, ImmuCell, Cue Biopharma, IO Biotech, and OS Therapies. More
Ascentage Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ascentage Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ascentage Pharma Group upside and downside potential and time the market with a certain degree of confidence.
Ascentage Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ascentage Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ascentage Pharma's standard deviation. In reality, there are many statistical measures that can use Ascentage Pharma historical prices to predict the future Ascentage Pharma's volatility.Ascentage Pharma Backtested Returns
We have found three technical indicators for Ascentage Pharma Group, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Ascentage Pharma are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Ascentage Pharma Group has perfect predictability. Overlapping area represents the amount of predictability between Ascentage Pharma time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ascentage Pharma price movement. The serial correlation of 1.0 indicates that 100.0% of current Ascentage Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Additional Information and Resources on Investing in Ascentage Pink Sheet
When determining whether Ascentage Pharma is a strong investment it is important to analyze Ascentage Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascentage Pharma's future performance. For an informed investment choice regarding Ascentage Pink Sheet, refer to the following important reports:Check out Ascentage Pharma Correlation, Ascentage Pharma Volatility and Ascentage Pharma Performance module to complement your research on Ascentage Pharma. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Ascentage Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.